MARKET

BIO

BIO

Bio Rad
NYSE

Real-time Quotes | Nasdaq Last Sale

788.35
+3.13
+0.40%
After Hours: 788.35 0 0.00% 16:23 09/17 EDT
OPEN
786.15
PREV CLOSE
785.22
HIGH
794.48
LOW
780.64
VOLUME
334.96K
TURNOVER
--
52 WEEK HIGH
832.70
52 WEEK LOW
490.73
MARKET CAP
23.47B
P/E (TTM)
5.88
1D
5D
1M
3M
1Y
5Y
10 Healthcare Stocks to Buy According to Mario Gabelli
In this article, we discuss the 10 healthcare stocks to buy according to Mario Gabelli. If you want to skip our detailed analysis of these stocks, go directly to the 5 Healthcare Stocks to Buy According to Mario Gabelli. Veteran investor Mario Gabelli is n...
Insider Monkey · 6h ago
Global Chromatography Instrumentation Market Industry Analysis, Size, Share, Growth, Trends and Forecast 2029
Research Nester published a report titled which delivers detailed overview of the global chromatography instrumentation market in terms of market segmentation by systems, consumables, application, and by region.
AmericaNewsHour · 1d ago
A Trio of Stocks for Growth-Oriented Investors
GuruFocus News · 2d ago
Bio-Rad (BIO) Upgraded to Strong Buy: Here's Why
Bio-Rad (BIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks · 2d ago
Predisposition Biomarkers Market- Expected Growth and its Factors, CAGR, Industry Size, Business Prospects and Forecast 2030
Research Nester published a report titled which delivers detailed overview of the global predisposition biomarkers market in terms of market segmentation by type, application, end-user, and by region.
AmericaNewsHour · 2d ago
Single Cell Genome Sequencing Market: Product Specification, Share, Size, Emerging Trends, Competitive Analysis and Forecast 2028
Research Nester published a report titled which delivers detailed overview of the global single cell genome sequencingmarket in terms of market segmentation by product, application, end user and by region.
AmericaNewsHour · 3d ago
Nucleic Acid Isolation and Purification Market: Product Specification, Share, Size, Emerging Trends, Competitive Analysis and Forecast 2028
Research Nester published a report titled which delivers detailed overview of the global nucleic acid isolation and purification market in terms of market segmentation by type, product, method, application, end-user and by region.
AmericaNewsHour · 3d ago
Bio-Rad Laboratories (BIO) Is Up 0.05% in One Week: What You Should Know
Zacks.com · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BIO. Analyze the recent business situations of Bio Rad through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BIO stock price target is 856.25 with a high estimate of 930.00 and a low estimate of 795.00.
EPS
Institutional Holdings
Institutions: 661
Institutional Holdings: 20.84M
% Owned: 70.00%
Shares Outstanding: 29.77M
TypeInstitutionsShares
Increased
189
1.26M
New
58
267.94K
Decreased
165
1.42M
Sold Out
41
305.42K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/President/Chief Executive Officer/Director
Norman Schwartz
Chief Financial Officer/Executive Vice President
Ilan Daskal
Chief Operating Officer/Executive Vice President
Andrew Last
Executive Vice President/General Counsel/Secretary
Timothy Ernst
Executive Vice President
Michael Crowley
Executive Vice President
Giovanni Magni
Executive Vice President
Annette Tumolo
Executive Vice President
Dara Wright
Vice President/Treasurer
Ronald Hutton
Lead Director/Independent Director
Gregory Hinckley
Director
Alice Schwartz
Independent Director
Jeffrey Edwards
Independent Director
Melinda Litherland
Independent Director
Arnold Pinkston
No Data
About BIO
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.

Webull offers kinds of Bio-Rad Laboratories, Inc. stock information, including NYSE:BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.